chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Dizziness, Nausea
Clinical narrative: Diarrhea; Lightheadedness; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea), DIZZINESS (Lightheadedness) and NAUSEA (Nausea) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history). Concomitant products included OMEPRAZOLE for an unknown indication.    On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, the patient experienced DIARRHOEA (Diarrhea), DIZZINESS (Lightheadedness) and NAUSEA (Nausea). On 03-Feb-2021, DIARRHOEA (Diarrhea), DIZZINESS (Lightheadedness) and NAUSEA (Nausea) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       no treatment details reported.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Peripheral swelling, Vaccination site erythema
Clinical narrative: extreme headache - 26 Feb 2021 (duration; current symptoms 28 feb 2021); arm swollen to size of baseball bat - 26 Feb 2021 (duration; current symptoms 28 feb 2021); redness on swollen arm - 26 Feb 2021 (duration; current symptoms 28 feb 2021); This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (extreme headache - 26 Feb 2021 (duration; current symptoms 28 feb 2021)), PERIPHERAL SWELLING (arm swollen to size of baseball bat - 26 Feb 2021 (duration; current symptoms 28 feb 2021)) and VACCINATION SITE ERYTHEMA (redness on swollen arm - 26 Feb 2021 (duration; current symptoms 28 feb 2021)) in a 79-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029L20A and 013A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HEADACHE (extreme headache - 26 Feb 2021 (duration; current symptoms 28 feb 2021)), PERIPHERAL SWELLING (arm swollen to size of baseball bat - 26 Feb 2021 (duration; current symptoms 28 feb 2021)) and VACCINATION SITE ERYTHEMA (redness on swollen arm - 26 Feb 2021 (duration; current symptoms 28 feb 2021)). At the time of the report, HEADACHE (extreme headache - 26 Feb 2021 (duration; current symptoms 28 feb 2021)), PERIPHERAL SWELLING (arm swollen to size of baseball bat - 26 Feb 2021 (duration; current symptoms 28 feb 2021)) and VACCINATION SITE ERYTHEMA (redness on swollen arm - 26 Feb 2021 (duration; current symptoms 28 feb 2021)) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Not able to make second appointment; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Detached retina repair on 19-Feb-2021. Concurrent medical conditions included Immunocompromised.   On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION. At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant product use was reported. On 19-Feb-2021, the patient underwent detached retina surgery. It was known that the operation was not planned before the administration of the vaccine and was not assumed to be a side effect of the vaccination.  Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 12-Apr-2021: Information was received from the patient indicating they were able to get their second dose with a few days to spare and they had no adverse reactions to either shot.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Feeling abnormal, Headache, Pain in extremity, Peripheral swelling
Clinical narrative: hot spots on finger joints; red rash/red rash; itchy rash/itchy rash; Chills; did not feel good; huge hives at the injection site; arm was warm to the touch; arm was lumpy; a terrific headache/headache; arm was hard; arm was swollen; Arm was sore/arm was sore; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills), HEADACHE (a terrific headache/headache), VACCINATION SITE INDURATION (arm was hard), VACCINATION SITE URTICARIA (huge hives at the injection site) and VACCINATION SITE WARMTH (arm was warm to the touch) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Jan-2021, the patient experienced PAIN IN EXTREMITY (Arm was sore/arm was sore). On 29-Jan-2021, the patient experienced VACCINATION SITE INDURATION (arm was hard) and PERIPHERAL SWELLING (arm was swollen). On 01-Feb-2021, the patient experienced HEADACHE (a terrific headache/headache). On 03-Feb-2021, the patient experienced VACCINATION SITE URTICARIA (huge hives at the injection site), VACCINATION SITE WARMTH (arm was warm to the touch), VACCINATION SITE MASS (arm was lumpy) and FEELING ABNORMAL (did not feel good). On 04-Feb-2021, the patient experienced CHILLS (Chills), RASH ERYTHEMATOUS (red rash/red rash) and RASH PRURITIC (itchy rash/itchy rash). On 06-Feb-2021, the patient experienced RASH PAPULAR (hot spots on finger joints). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 04-Feb-2021, VACCINATION SITE URTICARIA (huge hives at the injection site) had resolved. On 05-Feb-2021, VACCINATION SITE MASS (arm was lumpy) had resolved. On 06-Feb-2021, CHILLS (Chills) had resolved. On 07-Feb-2021, HEADACHE (a terrific headache/headache), VACCINATION SITE WARMTH (arm was warm to the touch) and FEELING ABNORMAL (did not feel good) had resolved. On 08-Feb-2021, VACCINATION SITE INDURATION (arm was hard), PAIN IN EXTREMITY (Arm was sore/arm was sore) and PERIPHERAL SWELLING (arm was swollen) had resolved. At the time of the report, RASH ERYTHEMATOUS (red rash/red rash), RASH PRURITIC (itchy rash/itchy rash) and RASH PAPULAR (hot spots on finger joints) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported by investigator o No treatment medications provided by the reporter.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Rash erythematous, Rash papular, Rash pruritic, Vaccination site induration, Vaccination site mass
Clinical narrative: hot spots on finger joints; red rash/red rash; itchy rash/itchy rash; Chills; did not feel good; huge hives at the injection site; arm was warm to the touch; arm was lumpy; a terrific headache/headache; arm was hard; arm was swollen; Arm was sore/arm was sore; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills), HEADACHE (a terrific headache/headache), VACCINATION SITE INDURATION (arm was hard), VACCINATION SITE URTICARIA (huge hives at the injection site) and VACCINATION SITE WARMTH (arm was warm to the touch) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Jan-2021, the patient experienced PAIN IN EXTREMITY (Arm was sore/arm was sore). On 29-Jan-2021, the patient experienced VACCINATION SITE INDURATION (arm was hard) and PERIPHERAL SWELLING (arm was swollen). On 01-Feb-2021, the patient experienced HEADACHE (a terrific headache/headache). On 03-Feb-2021, the patient experienced VACCINATION SITE URTICARIA (huge hives at the injection site), VACCINATION SITE WARMTH (arm was warm to the touch), VACCINATION SITE MASS (arm was lumpy) and FEELING ABNORMAL (did not feel good). On 04-Feb-2021, the patient experienced CHILLS (Chills), RASH ERYTHEMATOUS (red rash/red rash) and RASH PRURITIC (itchy rash/itchy rash). On 06-Feb-2021, the patient experienced RASH PAPULAR (hot spots on finger joints). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 04-Feb-2021, VACCINATION SITE URTICARIA (huge hives at the injection site) had resolved. On 05-Feb-2021, VACCINATION SITE MASS (arm was lumpy) had resolved. On 06-Feb-2021, CHILLS (Chills) had resolved. On 07-Feb-2021, HEADACHE (a terrific headache/headache), VACCINATION SITE WARMTH (arm was warm to the touch) and FEELING ABNORMAL (did not feel good) had resolved. On 08-Feb-2021, VACCINATION SITE INDURATION (arm was hard), PAIN IN EXTREMITY (Arm was sore/arm was sore) and PERIPHERAL SWELLING (arm was swollen) had resolved. At the time of the report, RASH ERYTHEMATOUS (red rash/red rash), RASH PRURITIC (itchy rash/itchy rash) and RASH PAPULAR (hot spots on finger joints) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported by investigator o No treatment medications provided by the reporter.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site urticaria, Vaccination site warmth
Clinical narrative: hot spots on finger joints; red rash/red rash; itchy rash/itchy rash; Chills; did not feel good; huge hives at the injection site; arm was warm to the touch; arm was lumpy; a terrific headache/headache; arm was hard; arm was swollen; Arm was sore/arm was sore; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills), HEADACHE (a terrific headache/headache), VACCINATION SITE INDURATION (arm was hard), VACCINATION SITE URTICARIA (huge hives at the injection site) and VACCINATION SITE WARMTH (arm was warm to the touch) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Jan-2021, the patient experienced PAIN IN EXTREMITY (Arm was sore/arm was sore). On 29-Jan-2021, the patient experienced VACCINATION SITE INDURATION (arm was hard) and PERIPHERAL SWELLING (arm was swollen). On 01-Feb-2021, the patient experienced HEADACHE (a terrific headache/headache). On 03-Feb-2021, the patient experienced VACCINATION SITE URTICARIA (huge hives at the injection site), VACCINATION SITE WARMTH (arm was warm to the touch), VACCINATION SITE MASS (arm was lumpy) and FEELING ABNORMAL (did not feel good). On 04-Feb-2021, the patient experienced CHILLS (Chills), RASH ERYTHEMATOUS (red rash/red rash) and RASH PRURITIC (itchy rash/itchy rash). On 06-Feb-2021, the patient experienced RASH PAPULAR (hot spots on finger joints). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 04-Feb-2021, VACCINATION SITE URTICARIA (huge hives at the injection site) had resolved. On 05-Feb-2021, VACCINATION SITE MASS (arm was lumpy) had resolved. On 06-Feb-2021, CHILLS (Chills) had resolved. On 07-Feb-2021, HEADACHE (a terrific headache/headache), VACCINATION SITE WARMTH (arm was warm to the touch) and FEELING ABNORMAL (did not feel good) had resolved. On 08-Feb-2021, VACCINATION SITE INDURATION (arm was hard), PAIN IN EXTREMITY (Arm was sore/arm was sore) and PERIPHERAL SWELLING (arm was swollen) had resolved. At the time of the report, RASH ERYTHEMATOUS (red rash/red rash), RASH PRURITIC (itchy rash/itchy rash) and RASH PAPULAR (hot spots on finger joints) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported by investigator o No treatment medications provided by the reporter.
Age: 43.0
Sex: M
Vaccine: COVID19
Symptoms: Neck pain, Vaccination site swelling
Clinical narrative: Sore neck; Swelling in the arm at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of NECK PAIN and VACCINATION SITE SWELLING in a 43-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History was provided by the reporter.     On 07-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced NECK PAIN (Sore neck) and VACCINATION SITE SWELLING. At the time of the report, NECK PAIN and VACCINATION SITE SWELLING outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. No treatment information was provided.   This case was linked to MOD-2021-029619 (Patient Link). Sender's Comments:  MOD-2021-029619:same reporter, different patient.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Left armpit is swollen up in the lymph nodes; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of LYMPHADENOPATHY (Left armpit is swollen up in the lymph nodes) in a 55-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Feb-2021, the patient experienced LYMPHADENOPATHY (Left armpit is swollen up in the lymph nodes). At the time of the report, LYMPHADENOPATHY (Left armpit is swollen up in the lymph nodes) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported by investigator o No treatment medications provided by the reporter.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, Asthenia, Body temperature increased, COVID-19, Feeding disorder
Clinical narrative: no taste; COVID-19; Feelings of weakness; very sick; headache; muscle aches; unable to eat; fever; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of ASTHENIA (Feelings of weakness), MALAISE (very sick), HEADACHE (headache), MYALGIA (muscle aches) and FEEDING DISORDER (unable to eat) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event. Concomitant products included OMEPRAZOLE for Acid reflux (esophageal), HYDROCHLOROTHIAZIDE for Hypertension, VITAMIN D [VITAMIN D NOS], VITAMIN C and ZINC for an unknown indication.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, the patient experienced ASTHENIA (Feelings of weakness), MALAISE (very sick), HEADACHE (headache), MYALGIA (muscle aches), FEEDING DISORDER (unable to eat) and PYREXIA (fever). On 26-Feb-2021, the patient experienced AGEUSIA (no taste) and COVID-19 (COVID-19). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, ASTHENIA (Feelings of weakness), MALAISE (very sick), HEADACHE (headache), MYALGIA (muscle aches), FEEDING DISORDER (unable to eat), PYREXIA (fever), AGEUSIA (no taste) and COVID-19 (COVID-19) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 24-Feb-2021, Body temperature increased: borderline (Borderline) 100.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient reports that he went to the hospital on 26-FEB-2021 and was positive for COVID virus. Patient remains in quarantine and symptoms are still present.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Malaise, Myalgia, Pyrexia
Clinical narrative: no taste; COVID-19; Feelings of weakness; very sick; headache; muscle aches; unable to eat; fever; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of ASTHENIA (Feelings of weakness), MALAISE (very sick), HEADACHE (headache), MYALGIA (muscle aches) and FEEDING DISORDER (unable to eat) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event. Concomitant products included OMEPRAZOLE for Acid reflux (esophageal), HYDROCHLOROTHIAZIDE for Hypertension, VITAMIN D [VITAMIN D NOS], VITAMIN C and ZINC for an unknown indication.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, the patient experienced ASTHENIA (Feelings of weakness), MALAISE (very sick), HEADACHE (headache), MYALGIA (muscle aches), FEEDING DISORDER (unable to eat) and PYREXIA (fever). On 26-Feb-2021, the patient experienced AGEUSIA (no taste) and COVID-19 (COVID-19). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, ASTHENIA (Feelings of weakness), MALAISE (very sick), HEADACHE (headache), MYALGIA (muscle aches), FEEDING DISORDER (unable to eat), PYREXIA (fever), AGEUSIA (no taste) and COVID-19 (COVID-19) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 24-Feb-2021, Body temperature increased: borderline (Borderline) 100.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient reports that he went to the hospital on 26-FEB-2021 and was positive for COVID virus. Patient remains in quarantine and symptoms are still present.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Dizziness, Feeling abnormal, Hypoaesthesia, Pain in extremity
Clinical narrative: Foggy; Dizziness; Joint pain came back; Elbow, arm, wrist and hand numbness; Debilitating sore on arm and some joints; Debilitating sore on arm and some joints; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA, FEELING ABNORMAL, DIZZINESS, PAIN IN EXTREMITY and ARTHRALGIA in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 21-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced HYPOAESTHESIA, PAIN IN EXTREMITY, and ARTHRALGIA. On 24-Jan-2021, the patient experienced FEELING ABNORMAL, DIZZINESS, and ARTHRALGIA. On 24-Jan-2021, HYPOAESTHESIA, PAIN IN EXTREMITY, and ARTHRALGIA had resolved. At the time of the report, FEELING ABNORMAL, DIZZINESS, and ARTHRALGIA had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported by investigator No treatment medications provided by the reporter.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Insomnia, Pain in extremity, Vaccination site pruritus, Vaccination site warmth
Clinical narrative: itches; warm at injection site; keeping her up at night; arm hurt/couldn't raise arm above head; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm hurt/couldn't raise arm above head), VACCINATION SITE PRURITUS (itches), VACCINATION SITE WARMTH (warm at injection site) and INSOMNIA (keeping her up at night) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Feb-2021, the patient experienced PAIN IN EXTREMITY (arm hurt/couldn't raise arm above head). On an unknown date, the patient experienced VACCINATION SITE PRURITUS (itches), VACCINATION SITE WARMTH (warm at injection site) and INSOMNIA (keeping her up at night). The patient was treated with Benadryl cream at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (arm hurt/couldn't raise arm above head) had not resolved and VACCINATION SITE PRURITUS (itches), VACCINATION SITE WARMTH (warm at injection site) and INSOMNIA (keeping her up at night) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported by investigator o No treatment medications provided by the reporter.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Lymph node pain, Lymphadenopathy, Peripheral swelling
Clinical narrative: Swollen Left supraclavicular lymph node; Left supraclavicular lymph node, tender; Fatigue; Swollen arm; This spontaneous case was reported by a health care professional and describes the occurrence of PERIPHERAL SWELLING (Swollen arm), FATIGUE (Fatigue), LYMPHADENOPATHY (Swollen Left supraclavicular lymph node) and LYMPH NODE PAIN (Left supraclavicular lymph node, tender) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025J20A and 030L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 05-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-Jan-2021, the patient experienced PERIPHERAL SWELLING (Swollen arm). On 07-Jan-2021, the patient experienced FATIGUE (Fatigue). On 08-Jan-2021, the patient experienced LYMPHADENOPATHY (Swollen Left supraclavicular lymph node) and LYMPH NODE PAIN (Left supraclavicular lymph node, tender). On 06-Jan-2021, PERIPHERAL SWELLING (Swollen arm) had resolved. On 13-Jan-2021, LYMPHADENOPATHY (Swollen Left supraclavicular lymph node) and LYMPH NODE PAIN (Left supraclavicular lymph node, tender) had resolved. At the time of the report, FATIGUE (Fatigue) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications reported by investigator o No treatment medications provided by the reporter.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Limb injury, Peripheral swelling, Vaccination site erythema, Vaccination site pruritus, Vaccination site rash
Clinical narrative: arm was bruised; My arm was swollen; m delayed injection site warm; delayed injection site red; delayed injection site itchy; delayed injection site rash; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of LIMB INJURY (arm was bruised), PERIPHERAL SWELLING (My arm was swollen), VACCINATION SITE WARMTH (m delayed injection site warm), VACCINATION SITE ERYTHEMA (delayed injection site red) and VACCINATION SITE PRURITUS (delayed injection site itchy) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced LIMB INJURY (arm was bruised), PERIPHERAL SWELLING (My arm was swollen), VACCINATION SITE WARMTH (m delayed injection site warm), VACCINATION SITE ERYTHEMA (delayed injection site red), VACCINATION SITE PRURITUS (delayed injection site itchy) and VACCINATION SITE RASH (delayed injection site rash). At the time of the report, LIMB INJURY (arm was bruised), PERIPHERAL SWELLING (My arm was swollen), VACCINATION SITE WARMTH (m delayed injection site warm), VACCINATION SITE ERYTHEMA (delayed injection site red), VACCINATION SITE PRURITUS (delayed injection site itchy) and VACCINATION SITE RASH (delayed injection site rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported by investigator o No treatment medications provided by the reporter.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site warmth
Clinical narrative: arm was bruised; My arm was swollen; m delayed injection site warm; delayed injection site red; delayed injection site itchy; delayed injection site rash; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of LIMB INJURY (arm was bruised), PERIPHERAL SWELLING (My arm was swollen), VACCINATION SITE WARMTH (m delayed injection site warm), VACCINATION SITE ERYTHEMA (delayed injection site red) and VACCINATION SITE PRURITUS (delayed injection site itchy) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced LIMB INJURY (arm was bruised), PERIPHERAL SWELLING (My arm was swollen), VACCINATION SITE WARMTH (m delayed injection site warm), VACCINATION SITE ERYTHEMA (delayed injection site red), VACCINATION SITE PRURITUS (delayed injection site itchy) and VACCINATION SITE RASH (delayed injection site rash). At the time of the report, LIMB INJURY (arm was bruised), PERIPHERAL SWELLING (My arm was swollen), VACCINATION SITE WARMTH (m delayed injection site warm), VACCINATION SITE ERYTHEMA (delayed injection site red), VACCINATION SITE PRURITUS (delayed injection site itchy) and VACCINATION SITE RASH (delayed injection site rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported by investigator o No treatment medications provided by the reporter.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Chills, Pain, Pyrexia
Clinical narrative: Body Ache; Fever (100.7); Extreme chills/Shiverning; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Body Ache), PYREXIA (Fever (100.7)) and CHILLS (Extreme chills/Shiverning) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 03M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Feb-2021, the patient experienced PAIN (Body Ache), PYREXIA (Fever (100.7)) and CHILLS (Extreme chills/Shiverning). At the time of the report, PAIN (Body Ache), PYREXIA (Fever (100.7)) and CHILLS (Extreme chills/Shiverning) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 100.7.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Diplopia, Lacrimation increased, Pain, Vision blurred
Clinical narrative: Pain; Chills; Blurred vision; Double vision; I could see my vitreous humour; Fluid in my eyes; This spontaneous case was reported by a physician and describes the occurrence of VISION BLURRED (Blurred vision), DIPLOPIA (Double vision), VITREOUS DISORDER (I could see my vitreous humour), LACRIMATION INCREASED (Fluid in my eyes) and PAIN (Pain) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included VITAMIN D NOS for an unknown indication.    On 21-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced VISION BLURRED (Blurred vision), DIPLOPIA (Double vision), VITREOUS DISORDER (I could see my vitreous humour) and LACRIMATION INCREASED (Fluid in my eyes). On 22-Jan-2021, the patient experienced PAIN (Pain) and CHILLS (Chills). The patient was treated with IBUPROFEN (MOTRIN [IBUPROFEN]) at an unspecified dose and frequency. On 21-Jan-2021, VISION BLURRED (Blurred vision), DIPLOPIA (Double vision), VITREOUS DISORDER (I could see my vitreous humour) and LACRIMATION INCREASED (Fluid in my eyes) had resolved. On 22-Jan-2021, CHILLS (Chills) had resolved. At the time of the report, PAIN (Pain) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Vitreous disorder
Clinical narrative: Pain; Chills; Blurred vision; Double vision; I could see my vitreous humour; Fluid in my eyes; This spontaneous case was reported by a physician and describes the occurrence of VISION BLURRED (Blurred vision), DIPLOPIA (Double vision), VITREOUS DISORDER (I could see my vitreous humour), LACRIMATION INCREASED (Fluid in my eyes) and PAIN (Pain) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included VITAMIN D NOS for an unknown indication.    On 21-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced VISION BLURRED (Blurred vision), DIPLOPIA (Double vision), VITREOUS DISORDER (I could see my vitreous humour) and LACRIMATION INCREASED (Fluid in my eyes). On 22-Jan-2021, the patient experienced PAIN (Pain) and CHILLS (Chills). The patient was treated with IBUPROFEN (MOTRIN [IBUPROFEN]) at an unspecified dose and frequency. On 21-Jan-2021, VISION BLURRED (Blurred vision), DIPLOPIA (Double vision), VITREOUS DISORDER (I could see my vitreous humour) and LACRIMATION INCREASED (Fluid in my eyes) had resolved. On 22-Jan-2021, CHILLS (Chills) had resolved. At the time of the report, PAIN (Pain) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Fatigue, Feeling hot, Myalgia, Swelling
Clinical narrative: Circle turned into darker, like a bruise at the injection site, still ongoing; swelled up; redness from her shoulder up to her right fingers; appeared a 1/4 red circle that lasted for 5 days, / Circle turned into darker, like a bruise at the injection site, still ongoing; hot from her shoulder up to her right fingers; sore right arm; felt tired; This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (hot from her shoulder up to her right fingers), VACCINATION SITE BRUISING (Circle turned into darker, like a bruise at the injection site, still ongoing), SWELLING (swelled up), ERYTHEMA (redness from her shoulder up to her right fingers) and VACCINATION SITE ERYTHEMA (appeared a 1/4 red circle that lasted for 5 days, / Circle turned into darker, like a bruise at the injection site, still ongoing) in a 26-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter. .  Concomitant products included supplements, ASCORBIC ACID, ROSA CANINA FRUIT (VITAMIN C & ROSEHIP) and ETHINYLESTRADIOL, FERROUS FUMARATE, NORETHISTERONE ACETATE (LO LOESTRIN FE) for an unknown indication.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Jan-2021, the patient experienced MYALGIA (sore right arm) and FATIGUE (felt tired). On 05-Feb-2021, the patient experienced FEELING HOT (hot from her shoulder up to her right fingers), SWELLING (swelled up), ERYTHEMA (redness from her shoulder up to her right fingers) and VACCINATION SITE ERYTHEMA (appeared a 1/4 red circle that lasted for 5 days, / Circle turned into darker, like a bruise at the injection site, still ongoing). On an unknown date, the patient experienced VACCINATION SITE BRUISING (Circle turned into darker, like a bruise at the injection site, still ongoing). On 30-Jan-2021, FATIGUE (felt tired) had resolved. On 01-Feb-2021, MYALGIA (sore right arm) had resolved. On 07-Feb-2021, SWELLING (swelled up) had resolved. At the time of the report, FEELING HOT (hot from her shoulder up to her right fingers), ERYTHEMA (redness from her shoulder up to her right fingers) and VACCINATION SITE ERYTHEMA (appeared a 1/4 red circle that lasted for 5 days, / Circle turned into darker, like a bruise at the injection site, still ongoing) had not resolved and VACCINATION SITE BRUISING (Circle turned into darker, like a bruise at the injection site, still ongoing) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient use ice in injection site.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site bruising, Vaccination site erythema
Clinical narrative: Circle turned into darker, like a bruise at the injection site, still ongoing; swelled up; redness from her shoulder up to her right fingers; appeared a 1/4 red circle that lasted for 5 days, / Circle turned into darker, like a bruise at the injection site, still ongoing; hot from her shoulder up to her right fingers; sore right arm; felt tired; This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (hot from her shoulder up to her right fingers), VACCINATION SITE BRUISING (Circle turned into darker, like a bruise at the injection site, still ongoing), SWELLING (swelled up), ERYTHEMA (redness from her shoulder up to her right fingers) and VACCINATION SITE ERYTHEMA (appeared a 1/4 red circle that lasted for 5 days, / Circle turned into darker, like a bruise at the injection site, still ongoing) in a 26-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter. .  Concomitant products included supplements, ASCORBIC ACID, ROSA CANINA FRUIT (VITAMIN C & ROSEHIP) and ETHINYLESTRADIOL, FERROUS FUMARATE, NORETHISTERONE ACETATE (LO LOESTRIN FE) for an unknown indication.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Jan-2021, the patient experienced MYALGIA (sore right arm) and FATIGUE (felt tired). On 05-Feb-2021, the patient experienced FEELING HOT (hot from her shoulder up to her right fingers), SWELLING (swelled up), ERYTHEMA (redness from her shoulder up to her right fingers) and VACCINATION SITE ERYTHEMA (appeared a 1/4 red circle that lasted for 5 days, / Circle turned into darker, like a bruise at the injection site, still ongoing). On an unknown date, the patient experienced VACCINATION SITE BRUISING (Circle turned into darker, like a bruise at the injection site, still ongoing). On 30-Jan-2021, FATIGUE (felt tired) had resolved. On 01-Feb-2021, MYALGIA (sore right arm) had resolved. On 07-Feb-2021, SWELLING (swelled up) had resolved. At the time of the report, FEELING HOT (hot from her shoulder up to her right fingers), ERYTHEMA (redness from her shoulder up to her right fingers) and VACCINATION SITE ERYTHEMA (appeared a 1/4 red circle that lasted for 5 days, / Circle turned into darker, like a bruise at the injection site, still ongoing) had not resolved and VACCINATION SITE BRUISING (Circle turned into darker, like a bruise at the injection site, still ongoing) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient use ice in injection site.
Sex: F
Vaccine: COVID19
Symptoms: Erythema
Clinical narrative: Bright redness on face; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Bright redness on face) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced ERYTHEMA (Bright redness on face). On 26-Feb-2021, ERYTHEMA (Bright redness on face) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient's medical history was not provided. No relevant concomitant medications were reported.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was unknown. On 26 Feb 2021 the outcome of event, bright redness on face was resolved.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Tachycardia, Tremor
Clinical narrative: real rapid heartrate with a duration of 4 hours; a lot of shaking with a duration of 4 hours; a lot of nausea with a duration of 4 hours; This spontaneous case was reported by a consumer and describes the occurrence of TACHYCARDIA (real rapid heartrate with a duration of 4 hours), TREMOR (a lot of shaking with a duration of 4 hours) and NAUSEA (a lot of nausea with a duration of 4 hours) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, the patient experienced TACHYCARDIA (real rapid heartrate with a duration of 4 hours), TREMOR (a lot of shaking with a duration of 4 hours) and NAUSEA (a lot of nausea with a duration of 4 hours). On 23-Feb-2021, TACHYCARDIA (real rapid heartrate with a duration of 4 hours), TREMOR (a lot of shaking with a duration of 4 hours) and NAUSEA (a lot of nausea with a duration of 4 hours) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported by investigator o No treatment medications provided by the reporter.
Sex: M
Vaccine: COVID19
Symptoms: Headache, Influenza like illness, Injection site pain, Pruritus, Rash
Clinical narrative: arm was sore; headache; flu-like symptoms; injection site was very red; rash; itchy; very hot to touch; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (arm was sore), HEADACHE (headache), INFLUENZA LIKE ILLNESS (flu-like symptoms), VACCINATION SITE ERYTHEMA (injection site was very red) and RASH (rash) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event. Concomitant products included METFORMIN, AMLODIPINE, LISINOPRIL, TAMSULOSIN, LEVOTHYROXINE, FINASTERIDE, DOXYCYCLINE and ATORVASTATIN for an unknown indication.    On 21-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced INJECTION SITE PAIN (arm was sore), HEADACHE (headache), INFLUENZA LIKE ILLNESS (flu-like symptoms), VACCINATION SITE ERYTHEMA (injection site was very red), RASH (rash), PRURITUS (itchy) and VACCINATION SITE WARMTH (very hot to touch). At the time of the report, INJECTION SITE PAIN (arm was sore), HEADACHE (headache), INFLUENZA LIKE ILLNESS (flu-like symptoms), VACCINATION SITE ERYTHEMA (injection site was very red), RASH (rash), PRURITUS (itchy) and VACCINATION SITE WARMTH (very hot to touch) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site warmth
Clinical narrative: arm was sore; headache; flu-like symptoms; injection site was very red; rash; itchy; very hot to touch; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (arm was sore), HEADACHE (headache), INFLUENZA LIKE ILLNESS (flu-like symptoms), VACCINATION SITE ERYTHEMA (injection site was very red) and RASH (rash) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event. Concomitant products included METFORMIN, AMLODIPINE, LISINOPRIL, TAMSULOSIN, LEVOTHYROXINE, FINASTERIDE, DOXYCYCLINE and ATORVASTATIN for an unknown indication.    On 21-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced INJECTION SITE PAIN (arm was sore), HEADACHE (headache), INFLUENZA LIKE ILLNESS (flu-like symptoms), VACCINATION SITE ERYTHEMA (injection site was very red), RASH (rash), PRURITUS (itchy) and VACCINATION SITE WARMTH (very hot to touch). At the time of the report, INJECTION SITE PAIN (arm was sore), HEADACHE (headache), INFLUENZA LIKE ILLNESS (flu-like symptoms), VACCINATION SITE ERYTHEMA (injection site was very red), RASH (rash), PRURITUS (itchy) and VACCINATION SITE WARMTH (very hot to touch) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.
Age: 67.0
Sex: U
Vaccine: COVID19
Symptoms: Headache, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: fever; headache; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever) and HEADACHE (headache) in a 67-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 (the patient was covid-19 positve) in July 2020.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, the patient experienced PYREXIA (fever) and HEADACHE (headache). At the time of the report, PYREXIA (fever) and HEADACHE (headache) had not resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In July 2020, SARS-CoV-2 test positive: (Positive) positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported by investigator o No treatment medications provided by the reporter.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Neck pain
Clinical narrative: Pain up the back of neck; Headache; This spontaneous case was reported by a consumer and describes the occurrence of NECK PAIN (Pain up the back of neck) and HEADACHE (Headache) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.    Concurrent medical conditions included Tinnitus. Concomitant products included ALPRAZOLAM (XANAX) for Tinnitus.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jan-2021, the patient experienced NECK PAIN (Pain up the back of neck) and HEADACHE (Headache). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, NECK PAIN (Pain up the back of neck) and HEADACHE (Headache) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Sore arm at the injection site; WARNING: THE STUDY CONFIGURATION IS MISSING THE STUDY PHASE. PLEASE UPDATE THE STUDY PHASE AND RE-GENERATE THE NARRATIVE AGAIN.    This     The subject received mRNA-1273 (Moderna COVID-19 Vaccine). The report describes a case of VACCINATION SITE PAIN (Sore arm at the injection site).     No medical history was provided by the reporter. .  Concomitant products included ATORVASTATIN CALCIUM (LIPITOR) and RAMIPRIL for an unknown indication.  On 10-Feb-2021, the patient experienced VACCINATION SITE PAIN (Sore arm at the injection site). At the time of the report, VACCINATION SITE PAIN (Sore arm at the injection site) had not resolved. Not Provided      No treatment medications provided by the reporter